Design of an Automatic System for the Control and Monitoring of Symptoms of Covid-19 through IoT Technology

The specific symptomatology of Covid-19 reveals discomfort with mild or moderate intensity depending on the body of each person. This article develops the design of an automatic device that encompasses an intelligent control and monitoring system for symptoms of covid-19, which allows determining and identifying an estimate of suspected cases of people who enter the Continental University-Peru, through a reading of patterns. The device was made covering three systems (mechanical, mechatronic and control), the integration of systems allowed an efficient design, dimensioned calculations in the mechanical, electrical, and electronic, and its integration of hardware-software for the graphical interface. The system presented allows real-Time monitoring of parameters captured by sensors with IOT technology, which has made it possible to deepen and estimate suspected cases of covid by comparing measured values with the ranges of values established by the American Medical Association. © 2022 IEEE.

Mitigating a COVID-19 outbreak among major league baseball players - United States, 2020

Mass gatherings have been implicated in higher rates of transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), and many sporting events have been restricted or canceled to limit disease spread. Based on current CDC COVID-19 mitigation recommendations related to events and gatherings, Major League Baseball (MLB) developed new health and safety protocols before the July 24 start of the 2020 season. In addition, MLB made the decision that games would be played without spectators. Before a three-game series between teams A and B, the Philadelphia Department of Public Health was notified of a team A player with laboratory-confirmed COVID-19;the player was isolated as recommended. During the series and the week after, laboratory-confirmed COVID-19 was diagnosed among 19 additional team A players and staff members and one team B staff member. Throughout their potentially infectious periods, some asymptomatic team A players and coaches, who subsequently received positive SARS-CoV-2 test results, engaged in on-field play with teams B and C. No on-field team B or team C players or staff members subsequently received a clinical diagnosis of COVID-19. Certain MLB health and safety protocols, which include frequent diagnostic testing for rapid case identification, isolation of persons with positive test results, quarantine for close contacts, mask wearing, and social distancing, might have limited COVID-19 transmission between teams.